The anatomy of regression-to-the-mean in simulated epilepsy trials
Using a large-scale simulation of epilepsy patients, this study demonstrates that regression to the mean can artificially inflate apparent placebo responses through distinct mechanisms—including transient illness worsening, stricter eligibility criteria, reduced measurement sensitivity, and false alarms—thereby providing critical insights for improving trial design and interpreting endpoints.